FDA Inspection 1306766 — Peptido, chemische und pharmazeutische Rohstoffgesellschaft mit beschrankter Haftung
The FDA completed an inspection of Peptido, chemische und pharmazeutische Rohstoffgesellschaft mit beschrankter Haftung on February 26, 2025 in Bexbach. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 26, 2025
- Fiscal Year
- 2025
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Bexbach (Germany)
Additional Details
Mutual Recognition Agreement (MRA)